Assignee
SEVERE ADVERSE EVENT SAE CONSORTIUM
US·0 granted patents·6 pending applications·0 citations·filing 2014–2015
Top patents by PatentIndex Score
6 records- 0151US2015105270A1Biomarkers for increased risk of drug-induced liver injury from exome sequencing studiesSEVERE ADVERSE EVENT SAE CONSORTIUM·Filed 2014·Application pending·0 cites
- 0251US2015105268A1Rare biomarkers for increased risk of drug-induced elongated qt interval and torsades de pointes from exome sequencing studiesSEVERE ADVERSE EVENT SAE CONSORTIUM·Filed 2014·Application pending·0 cites
- 0351US2015105269A1Biomarkers for increased risk of drug-induced osteonecrosis of the jawSEVERE ADVERSE EVENT SAE CONSORTIUM·Filed 2014·Application pending·0 cites
- 0451US2015105271A1Biomarkers for increased risk of drug-induced acute hypersensitivity syndromeSEVERE ADVERSE EVENT SAE CONSORTIUM·Filed 2014·Application pending·0 cites
- 0514US2016153046A1Biomarkers for Increased Risk of Drug-Induced Thiopurine-Induced PancreatitisSEVERE ADVERSE EVENT SAE CONSORTIUM·Filed 2015·Application pending·0 cites
- 0614US2016153045A1Biomarkers for Increased Risk of Drug-Induced 5-Aminosalicylate NephrotoxicitySEVERE ADVERSE EVENT SAE CONSORTIUM·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SEVERE ADVERSE EVENT SAE CONSORTIUM files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →